GoodRx Holdings (GDRX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on December 16. Analyst Michael Cherny from Leerink Partners reiterated a Buy ...

These medications are "slated to make a big clinical impact for those who need them," according to GoodRx, a California-based digital health care platform. How Are Prescription Drugs Named?

More than a year after its co-founders left the company, GoodRx will have a new president and CEO. On Monday, the consumer drug pricing and digital health company announced Wendy Barnes will take ...

Of the hundreds of drugs that entered the U.S. market in 2024, GoodRx has named 19 of them as the most notable. Note: The chronological list does not include December approvals. 1. Dupixent ...

Boehringer Ingelheim and Eli Lilly's SGLT2 inhibitor Jardiance has been approved for chronic kidney disease in the EU - the first major market to clear the new use for the drug. Adding CKD to the ...

The FDA has granted a speedy review of Eli Lilly and Boehringer Ingelheim’s Jardiance for a potential new use, to reduce the risk of renal failure and cardiovascular death in people with chronic ...

After hours: January 8 at 7:14:03 PM EST ...

Empagliflozin is under clinical development by Boehringer Ingelheim International and currently in Phase II for Pulmonary Arterial Hypertension. According to GlobalData, Phase II drugs for Pulmonary ...

The SGLT2 inhibitor empagliflozin did not lower the risk of a first hospitalization for heart failure (HF) or death from any cause among patients with an increased risk for HF following acute ...

Patients with acute myocardial infarction are at a high risk of heart failure and death. Despite advances in care and reduction in the rate of recurrent myocardial infarctions, the risk for heart ...